Activities per year
Activities
- 11 Conference presentation
- 11 results
Search results
-
The contact allergen methylisothiazolinone (MIT) activates TRPA1 to promote Th2-type inflammation in allergic contact dermatitis model
Mäki-Opas, I. (Speaker), Luostarinen, S. (Contributor), Hämäläinen, M. (Contributor), Muraki, K. (Contributor) & Moilanen, E. (Contributor)
28 Nov 2024 → 29 Nov 2024Activity: Talk or presentation › Conference presentation
-
The contact allergen methylisothiazoline (MIT) activates TRPA1 to promote Th2-type inflammation in allergic contact dermatitis model
Mäki-Opas, I. (Speaker), Luostarinen, S. (Contributor), Hämäläinen, M. (Contributor), Muraki, K. (Contributor) & Moilanen, E. (Contributor)
20 Mar 2024 → 22 Mar 2024Activity: Talk or presentation › Conference presentation
-
TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1 deficient mice in experimentally-induced scleroderma
Mäki-Opas, I. (Speaker), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor) & Scotece, M. (Contributor)
2 Jul 2023 → 7 Jul 2023Activity: Talk or presentation › Conference presentation
-
TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in experimentally induced scleroderma
Mäki-Opas, I. (Speaker), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor) & Scotece, M. (Contributor)
22 Mar 2023 → 24 Mar 2023Activity: Talk or presentation › Conference presentation
-
TRPA1 mediates DNCB-induced allergic contact dermatitis
Mäki-Opas, I. (Speaker), Hämäläinen, M. (Contributor), Moilanen, L. (Contributor), Sood, H. (Contributor), Leppänen, T. (Contributor), Lehtimäki, L. (Contributor) & Moilanen, E. (Contributor)
24 Aug 2022 → 26 Aug 2022Activity: Talk or presentation › Conference presentation
-
TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1 deficient mice in experimentally induced scleroderma
Mäki-Opas, I. (Speaker), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor) & Scotece, M. (Contributor)
5 May 2022 → 6 May 2022Activity: Talk or presentation › Conference presentation
-
TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1 deficient mice in experimentally induced scleroderma
Mäki-Opas, I. (Speaker), Hämäläinen, M. (Contributor), Moilanen, E. (Contributor) & Scotece, M. (Contributor)
25 Nov 2021 → 26 Nov 2021Activity: Talk or presentation › Conference presentation
-
TRPA1 mediates DNCB-induced allergic contact dermatitis
Mäki-Opas, I. (Contributor), Hämäläinen, M. (Contributor), Moilanen, L. (Contributor), Sood, H. (Contributor), Leppänen, T. (Contributor), Lehtimäki, L. (Contributor) & Moilanen, E. (Contributor)
29 Nov 2019Activity: Talk or presentation › Conference presentation
-
CAMP enhancing drugs salbutamol and rolipram augment the alternative activation of murine macrophages through MKP-1
Mäki-Opas, I. (Contributor), Scotece, M. (Contributor), Hämäläinen, M. (Contributor) & Moilanen, E. (Contributor)
15 Sept 2019Activity: Talk or presentation › Conference presentation
-
Pyrazine-fused triterpenoids block TRPA1 ion channel in vitro and inhibit TRPA1-mediated inflammation in vivo
Mäki-Opas, I. (Contributor), Hämäläinen, M. (Contributor) & Moilanen, E. (Contributor)
5 Sept 2018Activity: Talk or presentation › Conference presentation
-
Pyrazine-fused triterpenoids block TRPA1 ion channel in vitro and inhibit TRPA1-mediated inflammation in vivo
Mäki-Opas, I. (Contributor), Hämäläinen, M. (Contributor), Moilanen, L. (Contributor), Haavikko, R. (Contributor), Ahonen, T. (Contributor), Alakurtti, S. (Contributor), Moreira, V. (Contributor), Muraki, K. (Contributor), Yli-Kauhaluoma, J. (Contributor) & Moilanen, E. (Contributor)
1 Jun 2018Activity: Talk or presentation › Conference presentation